Compounds > hydroxyurea

hydroxyurea and fibrinogen

hydroxyurea has been researched along with fibrinogen in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kinoshita, S; Matsubuchi, T; Matsumiya, K; Nishimura, K; Oka, T; Takaha, M; Tsujimura, A; Yasui, M; Yasunaga, Y1
Ferro, TJ; Horvath, CJ; Jesmok, G; Malik, AB1
Bailie, MB; Fink, GD; Pearson, JM; Roth, RA1

Other Studies

3 other study(ies) available for hydroxyurea and fibrinogen

ArticleYear
[Clinical experience of urological surgery of the patients with hemostatic disorder or hemolytic disease].
    Hinyokika kiyo. Acta urologica Japonica, 1992, Volume: 38, Issue:11

    Topics: Adult; Aged; Blood Coagulation Factors; Blood Transfusion, Autologous; Child; Child, Preschool; Factor VIII; Female; Fibrinogen; Hemophilia B; Humans; Hydroxyurea; Lithotripsy; Male; Middle Aged; Spherocytosis, Hereditary; Thrombocythemia, Essential; Urologic Diseases; von Willebrand Diseases; Warfarin

1992
Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils.
    Proceedings of the National Academy of Sciences of the United States of America, 1988, Volume: 85, Issue:23

    Topics: Animals; Body Temperature; Capillary Permeability; Carbon Dioxide; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Hydroxyurea; Leukocyte Count; Male; Neutrophils; Oxygen; Pulmonary Circulation; Recombinant Proteins; Reference Values; Sheep; Tumor Necrosis Factor-alpha

1988
Neither platelet activating factor nor leukotrienes are critical mediators of liver injury after lipopolysaccharide administration.
    Toxicology, 1997, Sep-05, Volume: 121, Issue:3

    Topics: Administration, Oral; Alanine Transaminase; Animals; Azepines; Blood Platelets; Chemical and Drug Induced Liver Injury; Female; Fibrinogen; Hydroxyurea; Injections, Intraperitoneal; Injections, Intravenous; Leukotrienes; Lipopolysaccharides; Lipoxygenase Inhibitors; Liver; Liver Diseases; Necrosis; Neutrophils; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Thrombocytopenia; Triazoles

1997